Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Roger G Dale

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
International Journal of Radiation Oncology, Biology, Physics|February 8, 2003
Application of biological effective dose (BED) to estimate the duration of symptomatic relief and repopulation dose equivalent in palliative radiotherapy and chemotherapyBleddyn Jones, Matilda Cominos, Roger G Dale
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2004
Several important omissions in two recent articles concerned with radiation optic neuropathyBleddyn Jones, Charles Comins, Roger G Dale
International Journal of Radiation Biology|March 16, 2007
The incorporation of the concept of minimum RBE (RbEmin) into the linear-quadratic model and the potential for improved radiobiological analysis of high-LET treatmentsAlejandro Carabe-Fernandez, Roger G Dale, Bleddyn Jones
International Journal of Radiation Oncology, Biology, Physics|February 7, 2006
Linear quadratic modeling of increased late normal-tissue effects in special clinical situationsBleddyn Jones, Roger G Dale, Andrew M Gaya
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 12, 2008
Charged particle therapy for cancer: the inheritance of the Cavendish scientists?Bleddyn Jones, Roger G Dale, Alejandro Cárabe-Fernández
The British Journal of Radiology|December 21, 2019
Is there a role for arcing techniques in proton therapy?Alejandro Carabe-Fernandez, Alejandro Bertolet-Reina, Ilias Karagounis, et al.
International Journal of Radiation Oncology, Biology, Physics|January 16, 2003
The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy implantsChristina I Armpilia, Roger G Dale, Ian P Coles, et al.
Radiation Oncology (London, England)|October 21, 2018
Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicityChristy Goldsmith, P Nicholas Plowman, Melanie M Green, et al.
Physics in Medicine and Biology|May 22, 2004
A spatio-temporal simulation model of the response of solid tumours to radiotherapy in vivo: parametric validation concerning oxygen enhancement ratio and cell cycle durationVassilis P Antipas, Georgios S Stamatakos, Nikolaos K Uzunoglu, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2012
Ultra-short courses of adjuvant breast radiotherapy: promised land or primrose path?Atif J Khan, Douglas W Arthur, Roger G Dale, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
International Journal of Radiation Oncology, Biology, Physics|February 8, 2003
Application of biological effective dose (BED) to estimate the duration of symptomatic relief and repopulation dose equivalent in palliative radiotherapy and chemotherapyBleddyn Jones, Matilda Cominos, Roger G Dale
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|March 19, 2004
Several important omissions in two recent articles concerned with radiation optic neuropathyBleddyn Jones, Charles Comins, Roger G Dale
International Journal of Radiation Biology|March 16, 2007
The incorporation of the concept of minimum RBE (RbEmin) into the linear-quadratic model and the potential for improved radiobiological analysis of high-LET treatmentsAlejandro Carabe-Fernandez, Roger G Dale, Bleddyn Jones
International Journal of Radiation Oncology, Biology, Physics|February 7, 2006
Linear quadratic modeling of increased late normal-tissue effects in special clinical situationsBleddyn Jones, Roger G Dale, Andrew M Gaya
Applied Radiation and Isotopes : Including Data, Instrumentation and Methods for Use in Agriculture, Industry and Medicine|August 12, 2008
Charged particle therapy for cancer: the inheritance of the Cavendish scientists?Bleddyn Jones, Roger G Dale, Alejandro Cárabe-Fernández
The British Journal of Radiology|December 21, 2019
Is there a role for arcing techniques in proton therapy?Alejandro Carabe-Fernandez, Alejandro Bertolet-Reina, Ilias Karagounis, et al.
International Journal of Radiation Oncology, Biology, Physics|January 16, 2003
The determination of radiobiologically optimized half-lives for radionuclides used in permanent brachytherapy implantsChristina I Armpilia, Roger G Dale, Ian P Coles, et al.
Radiation Oncology (London, England)|October 21, 2018
Stereotactic ablative radiotherapy (SABR) as primary, adjuvant, consolidation and re-treatment option in pancreatic cancer: scope for dose escalation and lessons for toxicityChristy Goldsmith, P Nicholas Plowman, Melanie M Green, et al.
Physics in Medicine and Biology|May 22, 2004
A spatio-temporal simulation model of the response of solid tumours to radiotherapy in vivo: parametric validation concerning oxygen enhancement ratio and cell cycle durationVassilis P Antipas, Georgios S Stamatakos, Nikolaos K Uzunoglu, et al.
International Journal of Radiation Oncology, Biology, Physics|January 17, 2012
Ultra-short courses of adjuvant breast radiotherapy: promised land or primrose path?Atif J Khan, Douglas W Arthur, Roger G Dale, et al.
Pageof 3